{
    "clinical_study": {
        "@rank": "151559", 
        "brief_summary": {
            "textblock": "To evaluate the efficacy and safety of two doses of azithromycin given chronically for the\n      treatment of Mycobacterium avium bacteremia in AIDS patients."
        }, 
        "brief_title": "An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)", 
        "condition": [
            "Mycobacterium Avium-Intracellulare Infection", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Mycobacterium Infections", 
                "Mycobacterium avium-intracellulare Infection"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Medications allowed under a Treatment IND program.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  Disseminated Mycobacterium avium Complex.\n\n          -  Fever (> 100 degrees F) that cannot be attributed to another active infection, and at\n             least one other constitutional symptom (such as fatigue, malaise, anorexia).\n\n          -  Life expectancy of at least the duration of the study.\n\n          -  Consent of parent or guardian if below the legal age of consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms and conditions are excluded:\n\n          -  Known hypersensitivity or significant intolerance to macrolide antibiotics.\n\n          -  Inability to take oral medications or a current condition likely to interfere with\n             drug absorption (e.g., gastrectomy).\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Treatment with an immunostimulant or immunomodulator compound such as\n             alpha-interferon, gamma-interferon, or any interleukin within 7 days prior to study\n             entry.\n\n          -  Any other antibiotic with known activity against M. avium within 7 days prior to\n             study entry.\n\n        Not expected to comply with the requirements of the protocol, in the opinion of the\n        investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002090", 
            "org_study_id": "058H", 
            "secondary_id": "066-148"
        }, 
        "intervention": {
            "intervention_name": "Azithromycin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Azithromycin"
        }, 
        "keyword": [
            "Mycobacterium avium-intracellulare Infection", 
            "Acquired Immunodeficiency Syndrome", 
            "Azithromycin"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10468"
                    }, 
                    "name": "Bronx Veterans Affairs Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "SUNY / Health Sciences Ctr at Syracuse"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "Ohio State Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lackland Air Force Base", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78236"
                    }, 
                    "name": "United States Air Force Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Audie L Murphy Veterans Administration Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002090"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Audie L Murphy Veterans Administration Hosp": "29.424 -98.494", 
        "Beth Israel Hosp": "42.358 -71.06", 
        "Bronx Veterans Affairs Med Ctr": "40.85 -73.867", 
        "Ohio State Univ Hosp": "39.961 -82.999", 
        "SUNY / Health Sciences Ctr at Syracuse": "43.048 -76.147", 
        "United States Air Force Med Ctr": "29.384 -98.581"
    }
}